Page last updated: 2024-08-16

practolol and Leukemia, T-Cell

practolol has been researched along with Leukemia, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ladisch, S; Olshefski, RS	1

Other Studies

1 other study(ies) available for practolol and Leukemia, T-Cell

Article	Year
Glucosylceramide synthase inhibition enhances vincristine-induced cytotoxicity. International journal of cancer, 2001, Jul-01, Volume: 93, Issue:1 Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Survival; Drug Resistance, Multiple; Enzyme Inhibitors; Glucosyltransferases; Humans; Leukemia, T-Cell; Propanolamines; Pyrrolidines; Sphingolipids; Tumor Cells, Cultured; Vincristine	2001

Article

Year

Glucosylceramide synthase inhibition enhances vincristine-induced cytotoxicity.

International journal of cancer, 2001, Jul-01, Volume: 93, Issue:1

Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Survival; Drug Resistance, Multiple; Enzyme Inhibitors; Glucosyltransferases; Humans; Leukemia, T-Cell; Propanolamines; Pyrrolidines; Sphingolipids; Tumor Cells, Cultured; Vincristine

2001